Chondrosarcoma surgery

Revision as of 15:04, 13 March 2019 by Farima Kahe (talk | contribs) (→‎Surgery)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Chondrosarcoma Microchapters


Patient Information


Historical Perspective




Differentiating Chondrosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings


X Ray

Echocardiography and Ultrasound



Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chondrosarcoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Chondrosarcoma surgery

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chondrosarcoma surgery

CDC on Chondrosarcoma surgery

Chondrosarcoma surgery in the news

Blogs on Chondrosarcoma surgery

Directions to Hospitals Treating Chondrosarcoma

Risk calculators and risk factors for Chondrosarcoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rohan A. Bhimani, M.B.B.S., D.N.B., M.Ch.[2]


Surgery is the mainstay of treatment for chondrosarcoma. Adjunctive chemotherapy and radiation may be required. Recurrence rate depends on the grade of chondrosarcoma.


Intra-Lesional Curettage


Wide Surgical Excision


  • Grade 2 or 3 chondrosarcoma anywhere in the body.
  • Grade 1 chondrosarcoma in pelvis.

Wide Surgical Excision Combined with Multi-Agent Chemotherapy


  • Mesenchymal chondrosarcoma.

Limb-salvage through Pelvic Resection with or without Reconstruction


  • Dedifferentiated chondrosarcoma involving the pelvis.[6]

Limb-sacrifice with Hindquarter Amputation


  • Dedifferentiated chondrosarcoma involving the pelvis[6]

Recurrence Rate

Grade 1 chondrosarcoma

Grade 2 chondrosarcoma

  • The recurrence rate varies depending on resection margins.

Grade 3 chondrosarcoma

  • The local recurrence rate is 25% and >30% chances of metastasis.
Chondrosarcoma of glenoid and scapula. Source: Case courtesy by: Dr. Rohan A. Bhimani


  1. Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.
  2. Czerniak, Bogdan (2016). Dorfman and Czerniak's bone tumors. Philadelphia, PA: Elsevier/Saunders. ISBN 9780323023962.
  3. Lex JR, Evans S, Stevenson JD, Parry M, Jeys LM, Grimer RJ (2018). "Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment". Clin Sarcoma Res. 8: 23. doi:10.1186/s13569-018-0110-1. PMC 6293503. PMID 30559960.
  4. Ozaki T, Lindner N, Hillmann A, Rödl R, Blasius S, Winkelmann W (1996). "Influence of intralesional surgery on treatment outcome of chondrosarcoma". Cancer. 77 (7): 1292–7. doi:10.1002/(SICI)1097-0142(19960401)77:7<1292::AID-CNCR10>3.0.CO;2-X. PMID 8608505.
  5. Marco RA, Gitelis S, Brebach GT, Healey JH (2000). "Cartilage tumors: evaluation and treatment". J Am Acad Orthop Surg. 8 (5): 292–304. PMID 11029557.
  6. 6.0 6.1 Dickey ID, Rose PS, Fuchs B, Wold LE, Okuno SH, Sim FH; et al. (2004). "Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes". J Bone Joint Surg Am. 86-A (11): 2412–8. PMID 15523011.

Template:WikiDoc Sources